Hybridoma cells are commonly grown for the production of monoclonal antibodies (MAb). For monitoring and control purposes of the bioreactors, dynamic models of the cultures are required. However these models are difficult to infer from the usually limited amount of available experimental data and do not focus on target protein production optimization. This paper explores an experimental case study where hybridoma cells are grown in a sequential batch reactor. The simplest macroscopic reaction scheme translating the data is first derived using a maximum likelihood principal component analysis. Subsequently, nonlinear least-squares estimation is used to determine the kinetic laws. The resulting dynamic model reproduces quite satisfactorily th...
A generic model of cell growth and division cycles (CELCYMUS) is proposed. It is a one dimensional p...
CHO cell culture high productivity relies on optimized culture medium management under fed-batch or ...
A study was done to determine the viability improvement of hybridoma cell producing monoclonal antib...
Hybridoma cells are commonly grown for the production of monoclonal antibodies (MAb). For monitoring...
Monoclonal antibodies (mAbs) are at present one of the fastest growing products of pharmaceutical in...
Fed-batch cultures of hybridoma cells are commonly used for the production of monoclonal antibodies ...
Growth profiles of the batch and fed-batch culture of hybridoma cells producing monoclonal antibody ...
Monoclonal antibodies (MAbs) have an expanding market for use in diagnostic and therapeutic applicat...
This study aims at providing a methodology based on both data- and knowledge-driven approaches to bu...
Mammalian cell cultures are valuable for synthesis of therapeutic proteins and antibodies. They are ...
Monoclonal antibodies (MAbs) have extensive biomedical application and are produced in mammalian cel...
Monoclonal Antibodies (MAb) produced by hybridomas have an expanding market for use in diagnostic a...
Cultures of hybridoma cells in bioreactors are commonly used to produce monoclonal antibodies. As an...
Monoclonal Antibodies (MAb) produced by hybridomas have an expanding market for use in diagnostic a...
The purpose of this study is to approximate hybridoma growth kinetic model by comparing simulation r...
A generic model of cell growth and division cycles (CELCYMUS) is proposed. It is a one dimensional p...
CHO cell culture high productivity relies on optimized culture medium management under fed-batch or ...
A study was done to determine the viability improvement of hybridoma cell producing monoclonal antib...
Hybridoma cells are commonly grown for the production of monoclonal antibodies (MAb). For monitoring...
Monoclonal antibodies (mAbs) are at present one of the fastest growing products of pharmaceutical in...
Fed-batch cultures of hybridoma cells are commonly used for the production of monoclonal antibodies ...
Growth profiles of the batch and fed-batch culture of hybridoma cells producing monoclonal antibody ...
Monoclonal antibodies (MAbs) have an expanding market for use in diagnostic and therapeutic applicat...
This study aims at providing a methodology based on both data- and knowledge-driven approaches to bu...
Mammalian cell cultures are valuable for synthesis of therapeutic proteins and antibodies. They are ...
Monoclonal antibodies (MAbs) have extensive biomedical application and are produced in mammalian cel...
Monoclonal Antibodies (MAb) produced by hybridomas have an expanding market for use in diagnostic a...
Cultures of hybridoma cells in bioreactors are commonly used to produce monoclonal antibodies. As an...
Monoclonal Antibodies (MAb) produced by hybridomas have an expanding market for use in diagnostic a...
The purpose of this study is to approximate hybridoma growth kinetic model by comparing simulation r...
A generic model of cell growth and division cycles (CELCYMUS) is proposed. It is a one dimensional p...
CHO cell culture high productivity relies on optimized culture medium management under fed-batch or ...
A study was done to determine the viability improvement of hybridoma cell producing monoclonal antib...